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Mathematical Modeling and Simulations of the
Pathophysiology of Type-2 Diabetes Mellitus
Frank Nani and Mingxian Jin
Department of Mathematics and Computer Science
Fayetteville State University
Fayetteville, NC 28301, USA
Abstract --The pathophysiology of Type 2 Diabetes Mellitus
(T2DM) is modelled using a coupled system of non-linear
deterministic differential equations. An attempt is made to
construct to a clinically plausible mathematical model that
incorporates the homeostasis associated with endocrinological
regulation of glucose and glycogen levels in the human body, by
the hormones, insulin and glucagon. The model variables include
the concentrations of glucose in the venous blood plasma, the
concentration of glycogen in the liver/tissues, the concentration of
the hormone glucagon, and the concentration of insulin in the
venous blood plasma. The physiological interactions between the
model parameters are depicted by clinically measurable rate
constants and biophysically quantifiable stoichiometric
coefficients. The processes of gluconeogenesis, glycogenolysis, and
pulsatile insulin secretion during type 2 diabetes are modelled
using plausible auxiliary functions. Investigative computer
simulations are performed to elucidate various hypothetical
scenarios of glycemia, patho-physiology of T2DM and insulinoma
associated hypoglycemia which results from excessive insulin
production probably due to a tumor.
This study has
demonstrated the necessity of simultaneous monitoring of plasma
glucose, glucagon, insulin, and glycogen levels in the proper
assessment of the pathophysiology of type 2 diabetes and during
determination of the therapeutic efficacy of anti-diabetic drugs.
Keywords--Mathematical modeling; diabetes mellitus; dynamics
of glucose; glycogen; glucagon; insulin

I.

INTRODUCTION

Type 2 diabetes mellitus (T2DM) is characterized by
insulin resistance, insulin hypo-secretion to β cell impairment
and/or over production of glucose. A person is diagnosed as
diabetic if the fasting venous plasma glucose concentration is
greater than 126 mg/dL and/or the 2-hour post-glucose load of
75g of anhydrous glucose yield a venous plasma glucose
concentration of 200 mg/dL [1]. Alternative novel tests for
diagnosis include the use of glycated hemoglobin (HbA1C) with
suggested levels of about 6.5% [2].
The pre-disposing historical high risk factors for T2DM
include increasing age (old age), central obesity, dietary
polyphagia of animal fats, carbonated drinks, lack of physical
exercises, familial genetic factors, history of gestational
diabetes, polycystic ovary syndrome, and severe mental
illness, presence of hypertension, hyperlipidemia, ethnicity
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and cardio-metabolic factors. Recent emerging risk factors
include sleep deprivation, drug-induced metabolic changes,
environmental pollutants, low birth weight and fetal
malnutrition [3, 4, 5, 6, 7].
Many mathematical models in the literature were devoted
mainly to the dynamics of glucose in relation to the hormone,
insulin. The basic model was proposed by Bolie [9], who used
the following system of ordinary differential equations
dG
= − a 1G − a 2 I + P
dt
dI
= − a 3G − a 4 I
dt

(1.1)

where G = G(t) represents glucose concentration, I = I(t)
represents insulin concentration, and P, a1, a2, a3, a4 are model
parameters.
A clinically relevant minimal model of glucose-insulin
dynamics was proposed by Bergman, Bowden, and Cobelli in
[10]. De Gaetano Arino [11] constructed a dynamical model of
insulin-glucose dynamics using an aggregated integrodifferential delay equations. Several other models were
constructed by the following authors: Li et. al. [12], Cobelli
and Tomaseth [13], Lam et. al. [14], Mari [8].
The main objective of the research presented in this
paper is to construct a clinically plausible model that depicts
the homeostasis of glucose-insulin regulatory dynamics and
the pathophysiology of T2DM.
II.

DEFINITIONS OF MODEL PARAMETERS

The explicit non-linear deterministic mathematical
equations describing the patho-physiology of T2DM are
presented in this section.

x 1 ( t ) : the concentration of glucose in the blood plasma of
the patient at any time t during T2DM.
:
x 2 ( t ) the concentration of glycogen in the blood plasma of
the patient at any time t during T2DM.
x 3 ( t ) : the concentration of glucagon in the blood plasma of
the patient at any time t during T2DM.
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x 4 ( t ) : the concentration of insulin in the blood plasma of
the patient at any time t during T2DM.
G i ( x i ) : the rate constant depicting exogenous input into the
ith compartment by either post-prandial uptake or
intravenous (i.v.) infusion or by subcutaneous injection
[ i = 1, 2 ,3, 4 ] .
S1 (x3 , x4 ) :

the rate of hepatic glucose synthesis by

gluconeogenesis
S 2 ( x 3 , x 4 ) : the rate of glycogen bio-synthesis.
S 3 ( x 1 , x 2 ) : the rate of glucagon bio-synthesis in alpha cells
of the pancreas.

S 4 ( x 1 , x 4 ) : the rate of insulin bio-synthesis in beta cells of
the pancreas.
In particular, the following homeostasis functions are
used:
S1 ( x3 , x4 ) =

c1 x 3
1 + μ1x4

S 2 (x3 , x4 ) =

c2x4
1 + μ 2 x3

S 3 ( x1 , x 2 ) =

c3 x2
1 + μ 3 x1

(2.1)

k i : the rate constant depicting catabolic degradation
[ i = 1, 2 ,3, 4 ] pertaining to exponential decay kinetics.

k0i : the rate constant depicting catabolic degradation
[ i = 1, 2 ,3, 4 ] pertaining to linear decay kinetics.
( a 14 , a 41 ) : stoichiometric kinetic constant involved in the
action of insulin ( x 4 ) on glucose ( x 1 ) .
stoichiometric kinetic constant involved in the
production of glycogen.

( a 23 , a 32 ) : stoichiometric kinetic constant involved in the
action of glucagon ( x 3 ) on glycogen ( x 2 ) .

σ1 : stoichiometric kinetic constant involved in the production
of glucose.
fi (t) =

⎡sin nt ⎤ represents pulsatile input function for each i

[ i = 1, 2 ,3, 4 ] .
III.

the rate of loss of glucose during glycogenesis due to action of
insulin on glucose ( a 14 x 1 x 4 ), minus the rate of catabolism of
glucose during glycolysis ( k1 x1 ), minus the linear rate of
degradation of glucose by utilization during exercise and
physiologic activity in the brain, skeletal muscles and cardiac
muscles ( k01 ). The glucose dynamics equation is shown as
below:

dx1
= G1 f1 (t ) + S1 ( x3 , x 4 ) + σ 1 x2 x3 − a14 x1 x4 − k1 x1 − k 01
dt
(3.1)

c 4 x1
S 4 ( x1 , x 2 ) =
1 + μ 4 x2

σ2 :

A. The Glucose Dynamics Equation
The rate of change of glucose in the body is equal to the
post prandial input ( G 1 f 1 ( t ) ), plus the rate of glucose
production by gluconeogenesis (S1(x3, x4)) which is breakdown
of pyruvate into glucose mediated by insulin and glucagon,
plus the rate of glucose production by glycogenolysis
involving action of glucagon on glycogen ( σ 1 x 2 x 3 ), minus

MODEL EQUATIONS FOR TYPE-2 DIABETES MELLITUS

In this section, an elaborate physiological description and
mathematical formulation of the model equations are
presented.

B. The Glycogen Dynamics Equation
Glycogen dynamical equation depends on the postprandial rate of glycogen input G 2 f 2 ( t ) ; the bio-synthesis of
glycogen term S2(x3, x4) which is mediated by glucagon and
insulin and stored in body tissues including muscle; the rate of
de novo synthesis of glycogen due to action of insulin on
glucose ( σ 2 x 1 x 4 ) and mediated by glycogen synthase; the
rate of catabolism of glycogen by glycogenolysis in liver (
rate
of
loss
of
glycogen
by
− a 23 x 2 x 3 );
enzymatic/exponential degradation mediated by glycogen
phosphorylase (–k2x2); and rate of linear degradation of
glycogen (–k02). The catabolic breakdown of glycogen is
mediated primarily by glucagon but there are other hormones
that are involved. These include cortisol, somatotropin, and
catecholamines. The glycogen dynamical equation thus takes
the form:

dx 2
= G2 f 2 (t ) + S 2 ( x3 , x4 ) + σ 2 x1 x4 − a 23 x2 x3 − k 2 x2 − k 02
dt
(3.2)
C. The Glucagon Dynamics Equation
The rate of change of glucagon in the body equals to the
rate of exogenous input (G3f3(t)) by intravenous or intramuscular injection, plus rate of biosynthesis of glucagon and
glycogen (S3(x1, x2)) mediated by the levels of glucose and
glycogen, minus the rate of loss of glucagon during
glycogenolysis (a32 x2 x3) in the liver, minus degradation of
glucagon enzymatically (k3x3), and minus linear catabolism of
glucagon (k03). The glucagon dynamical equation thus takes
the following form:
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dx 3
= G 3 f 3 (t ) + S 3 ( x1 , x 2 ) − a 32 x 2 x3 − k 3 x3 − k 03
dt
(3.3)

x1-Glucose

D. The Insulin Dynamics Equation
The rate of change of insulin in the venous blood plasma
is equal to the rate of exogenous input (G4f4(t)) by intravenous or sub-cutaneous injection, plus the bio-synthesis of
insulin in the β-cells of the islets of Langerhans in the
pancreas mediated by the relative concentrations of glucose
and glycogen ((S4(x1, x2)), minus the rate of insulin catabolism
during the mediation of conversion of glucose to glycogen (a41
x1 x4), minus the exponential degradation of insulin (k4x4),
minus the linear degradation of insulin (k03). Thus the insulin
dynamical equation takes the form:

200

200

150

150

100

100

50

50

0

0
0

10

COMPUTER SIMULATION RESULTS AND DISCUSSION

fi (t) =

⎡sin nt ⎤ where n = 24

The time scale for all simulations is hours. The values of
rate constants are all estimated and are hypothetical. The units
for variables x1, x2, x3, and x4 are as follow: x1(mg/dL), x2(g),
x3(pg/mL), and x4(μlU/mL).
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In this section, investigative computer simulations are
performed to elucidate some aspects of T2DM
pathophysiology using hypothetical clinical parametric
configurations. For all the simulations, the pulsatile input
function fi(t) is defined by the formula:
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x3 - Glucagon

dx 4
= G 4 f 4 ( t ) + S 4 ( x1 , x 2 ) − a 41 x1 x 4 − k 4 x 4 − k 04
dt
(3.4)
IV.

x2-Glycogen
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Figure 1. Simulation results using parametric configuration P1

As shown in Figure 1, the dynamics of glucose,
glycogen, glucagon, and insulin in hypothetical patient #1
seems normal. In particular, the steady status values are
approximately 180 mg/dL for x1, 160g for x2, 40 pg/mL for x3,
and 10~15 mIU/mL for x4. Compared with the standard
ranges, the patient's glucose, glycogen, glucagon and insulin
levels are regulated by feedback homeostasis.

B. Hypothetical Patient #2

A. Hypothetical Patient #1
TABLE II. PARAMETRIC CONFIGURATION Ρ2

TABLE I. PARAMETRIC CONFIGURATION Ρ1
G1 = 90.0
c1 = 0.25
μ1 = 0.8
σ1 = 0.25
k1 = 2.85
a14 = 0.50
k01 = 10.50
x10 = 90

G2 = 20
c2 = 0.975
μ2 = 0.7
σ2 = 0.35
a23 = 0.1
k2 = 0.95
k02 = 0.75
x20 = 80

G3 = 20
c3 = 10.5
μ3 = 0.009
a32 = 0.1
k3 = 0.00001
k03 = 0.00015
x30 = 100

G4 = 50
c4 = 25.0
μ4 = 0.085
a41 = 0.15
k4 = 0.0001
k04 = 0.0025
x40 = 20

G1 = 90.0
c1 = 0.25
μ1 = 1
σ1 = 0.55
k1 = 1.5
a14 = 0.50
k01 = 7.50
x10 = 90
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G2 = 20
c2 = 0.975
μ2 = 1
σ2 = 0.45
a23 = 0.5
k2 = 0.95
k02 = 0.75
x20 = 80

G3 = 20
c3 = 3.75
μ3 = 1
a32 = 0.0175
k3 = 0.001
k03 = 0.0015
x30 = 100

G4 = 50
c4 = 3.85
μ4 = 1
a41 = 0.09
k4 = 0.0001
k04 = 0.0025
x40 = 20
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Figure 2. Simulation results using parametric configuration P2

Figure 3. Simulation results using parametric configuration P3

An inspection of the dynamics of glucose, glycogen,
glucagon and insulin in hypothetical patient #2 shown in
Figure 2 reveals that this patient has hyperglycemia and low
insulin levels. Thus the patient is either pre-diabetic or
diabetic.

The glucose, glycogen, glucagon, and insulin profile of
hypothetical patient #3 shows that almost perfect homeostasis
as shown in Figure 3. All the values are in the normal ranges.
This this patient is free of diabetes.

C. Hypothetical Patient #3

D. Hypothetical Patient #4

TABLE III. PARAMETRIC CONFIGURATION Ρ3
G1 = 90.0
c1 = 0.25
μ1 = 0.95
σ1 = 0.55
k1 = 1.5
a14 = 0.05
k01 = 7.50
x10 = 90

G2 = 20
c2 = 0.975
μ2 = 0.85
σ2 = 0.45
a23 = 0.5
k2 = 0.95
k02 = 0.75
x20 = 80

G3 = 20
c3 = 3.75
μ3 = 0.75
a32 = 0.0175
k3 = 0.001
k03 = 7.5
x30 = 100

G4 = 50
c4 = 3.85
μ4 = 0.70
a41 = 0.09
k4 = 0.0001
k04 = 0.0025
x40 = 20

TABLE IV. PARAMETRIC CONFIGURATION Ρ4
G1 = 90.0
c1 = 0.25
μ1 = 0.8
σ1 = 0.25
k1 = 4.85
a14 = 0.5
k01 = 10.50
x10 = 90
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G2 = 20
c2 = 0.975
μ2 = 0.7
σ2 = 0.35
a23 = 0.1
k2 = 2.5
k02 = 0.75
x20 = 80

G3 = 60
c3 = 40
μ3 = 0.000009
a32 = 1.5
k3 = 0.05
k03 = 0.15
x30 = 100

G4 = 50
c4 = 25
μ4 = 0.0085
a41 = 0.09
k4 = 0.00001
k04 = 0.0025
x40 = 60

x1-Glucose

x2-Glycogen
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Figure 4. Simulation results using parametric configuration P4

In Figure 4, the hypothetical patient #4 exhibits the
clinical manifestations of hypoglycemia which could be
probably due to insulinoma that produces excessive levels of
insulin that depletes the glucose levels by converting them into
glycogen.
V.

CONCLUSION AND DISCUSSION

This research shows the relative importance of
mathematical modeling in diabetes research. The major hurdle
is how to acquire clinically relevant data to validate the model
and perform simulations. The use of Michaelis-Menten type
functions make it extremely difficult to estimate the values of
the rate constants. In order to solve this problem, hypothetical
estimates were used. In the future, more realistic parametric
estimates will be used. Nevertheless, this model is one of the
first to attempt to describe the pathophysiology of Type 2
Diabetes Mellitus by incorporating most of the physiological
aspects of the homeostasis of glucose, glycogen, glucagon and
insulin. The computer simulations demonstrate the usefulness
of the model equations in describing endocrinopathies
associated with insulin and glucagon.
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